Assignee
AMPLA PHARMACEUTICALS INC
US·0 granted patents·7 pending applications·0 citations·filing 2007–2009
Top patents by PatentIndex Score
7 records- 0161US2009036426A1CB1 antagonists and inverse agonistsAMPLA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0260US2008182898A1Treatment of metabolic syndrome with norfluoxetineAMPLA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0355US2009239909A1Treatment of metabolic syndrome with lactamsAMPLA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0449US2008140450A1Treatment of metabolic syndrome with norfluoxetineAMPLA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 0549US2010292289A1Treatment of metabolic syndrome with novel amidesAMPLA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0649US2008027087A1CB1 antagonists and inverse agonistsAMPLA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 0742US2008027072A1Potentiation of MC4 receptor activityAMPLA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →